
Cyntegrity is an innovative German company specializing in AI-augmented risk-based quality management (RBQM) solutions for clinical trials. Their integrated suite enhances operational efficiency, reduces costs, and improves compliance and predictability in clinical studies. With a focus on data quality, reliability, and patient safety, Cyntegrity offers tailored solutions that adapt to the specific needs of each client. They have achieved significant traction with over 1,000 studies in their portal, 627 studies actively managed, and a strong educational component with over 1,000 students enrolled in their academy. Their market position is bolstered by certifications such as ISO/IEC 27001:2022 and SOC2 Type 2, ensuring high standards of data security and compliance.

Cyntegrity is an innovative German company specializing in AI-augmented risk-based quality management (RBQM) solutions for clinical trials. Their integrated suite enhances operational efficiency, reduces costs, and improves compliance and predictability in clinical studies. With a focus on data quality, reliability, and patient safety, Cyntegrity offers tailored solutions that adapt to the specific needs of each client. They have achieved significant traction with over 1,000 studies in their portal, 627 studies actively managed, and a strong educational component with over 1,000 students enrolled in their academy. Their market position is bolstered by certifications such as ISO/IEC 27001:2022 and SOC2 Type 2, ensuring high standards of data security and compliance.
Headquarters: Frankfurt, Germany
Product: MyRBQM® Portal — AI-augmented RBQM SaaS for clinical trials
Founded: 2014
Employees: 35
Compliance: ISO/IEC 27001:2022 and SOC 2 Type 2
Risk-based quality management and clinical-trial analytics to ensure data integrity and patient safety.
2014
Clinical trials / Health care / Pharmaceutical software
Single funding event listed as non-equity assistance on public profiles; financial details obfuscated.